|
SAMD9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.018100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.719000E-01 |
| Normal-vs-Stage2 |
3.395000E-01 |
| Normal-vs-Stage3 |
1.470190E-01 |
| Normal-vs-Stage4 |
8.094300E-02 |
| Stage1-vs-Stage2 |
6.344000E-01 |
| Stage1-vs-Stage3 |
4.679200E-01 |
| Stage1-vs-Stage4 |
2.480800E-01 |
| Stage2-vs-Stage3 |
9.253600E-01 |
| Stage2-vs-Stage4 |
8.279600E-01 |
| Stage3-vs-Stage4 |
6.379400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.464500E-02 |
| Normal-vs-AfricanAmerican |
2.781800E-01 |
| Normal-vs-Asian |
1.322010E-01 |
| Caucasian-vs-AfricanAmerican |
2.258500E-03 |
| Caucasian-vs-Asian |
5.187400E-01 |
| AfricanAmerican-vs-Asian |
5.301900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.283600E-02 |
| Normal-vs-Female |
1.861750E-01 |
| Male-vs-Female |
7.118200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.397200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.227580E-01 |
| Normal-vs-Age(61-80Yrs) |
1.478650E-01 |
| Normal-vs-Age(81-100Yrs) |
8.380800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.984600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.642200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.221800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.462400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.394600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.530000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.009600E-01 |
| Normal-vs-Grade 2 |
8.675600E-02 |
| Normal-vs-Grade 3 |
6.241600E-01 |
| Normal-vs-Grade 4 |
1.353970E-02 |
| Grade 1-vs-Grade 2 |
6.413000E-01 |
| Grade 1-vs-Grade 3 |
2.917400E-01 |
| Grade 1-vs-Grade 4 |
4.355400E-01 |
| Grade 2-vs-Grade 3 |
1.041760E-01 |
| Grade 2-vs-Grade 4 |
1.333620E-01 |
| Grade 3-vs-Grade 4 |
1.705800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.751800E-01 |
| Normal-vs-ccB subtype |
4.333900E-02 |
| ccA subtype-vs-ccB subtype |
3.815200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.492100E-02 |
| Normal-vs-N1 |
1.424620E-01 |
| N0-vs-N1 |
2.807600E-01 |
|
|
